Foamix Pharmaceuticals Ltd. Derivative Asset, Current
Foamix Pharmaceuticals Ltd. had Derivative Asset, Current of $12.00 thousand as of 2019-03-31, per its 10-Q filed 2019-05-07.
Discontinued › Balance Sheet › Assets › Assets, Current
us-gaap:DerivativeAssetsCurrent · last filed 2020-03-12
- 2019-03-31: Derivative Asset, Current $12.00K.
- 2018-12-31: Derivative Asset, Current -$3.00K.
- 2018-03-31: Derivative Asset, Current -$9.00K.
- 2017-12-31: Derivative Asset, Current $11.00K.
| Period end | Derivative Asset, Current |
|---|---|
| 2019-03-31 | $12.00K 10-Q · filed 2019-05-07 |
| 2018-12-31 | -$3.00K 10-K · filed 2020-03-12 |
| 2018-03-31 | -$9.00K 10-Q · filed 2018-05-08 |
| 2017-12-31 | $11.00K 10-K · filed 2019-02-28 |
| 2016-12-31 | $2.00K 10-K · filed 2018-03-01 |